ArticleOncoimmunology

Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice.

Kathleen M Kokolus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.